-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with acute ischemic stroke or transient ischemic attack (TIA) have an approximately 10% to 17% risk of recurring stroke within the first year after the onset of symptoms
.
Intensified quality improvement has been shown to improve the prognosis of stroke
Stroke management to prevent thrombosis and diabetes
However, for patients who continue to adhere to the guideline-based secondary prevention of stroke, the residual risk of stroke recurrence has not been estimated
.
In addition, despite the implementation of these evidence-based therapies, there is still a large risk of stroke recurrence, which shows that current guideline-based interventions do not fully consider all the ways that lead to stroke recurrence
Blood vessel
In this way, Yuesong Pan and others of Beijing Tiantan Hospital used the prospective registration data (Third China National Stroke Registry, CNSR-III) of patients with acute ischemic stroke and TIA across China to evaluate adherence to the guideline-based secondary The risk of recurrence of acute ischemic stroke or TIA for stroke prevention, and the risk factors for residual risk are determined
.
Using prospective registration data (Third China National Stroke Registry, CNSR-III) of patients with acute ischemic stroke and TIA nationwide in China, we evaluated the recurrence of acute ischemic stroke or TIA that adhere to guideline-based secondary stroke prevention Risk, and determine the risk factors of residual risk
.
Using prospective registration data (Third China National Stroke Registry, CNSR-III) of patients with acute ischemic stroke and TIA nationwide in China, we evaluated the recurrence of acute ischemic stroke or TIA that adhere to guideline-based secondary stroke prevention Risk, and determine the risk factors for residual risk
The main clinical outcome was a new stroke at 12 months
.
Among the 9,022 patients included (median age 63.
0 years, 31.
7% women), 3,146 (34.
They found that 864 of them (9.
6%) had a recurrent stroke within 12 months, and the remaining risk for patients who adhered to guideline-based secondary prevention was 8.
3%
.
Compared with patients who did not adhere to guideline treatment, patients who adhered to guideline-based secondary prevention had a lower rate of recurrence stroke within 12 months (HR=0.
Patients who adhere to guideline-based secondary prevention have a lower rate of recurrent stroke within 12 months.
The significance of this study is that it has found that even in patients who continue to adhere to guideline-based secondary stroke prevention, there is still a large residual risk of recurring stroke at 12 months
.
Future research should focus on reducing residual risks
Even in patients who continue to comply with guideline-based secondary stroke prevention, there is still a large residual risk of recurring stroke at 12 months
Leave a message here
